Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

New Software for Malvern’s NanoSight NTA Systems

Published: Friday, July 18, 2014
Last Updated: Thursday, July 17, 2014
Bookmark and Share
NTA 3.0 from Malvern improves user experience and enhances performance.

Malvern Instruments has launched NTA 3.0, a new version of the software that drives its NanoSight Nanoparticle Tracking Analysis (NTA) systems. With an improved, easy-to-use interface, the new NTA 3.0 software makes accessing programs and protocols quick and convenient.

It also incorporates an upgraded high-resolution particle size distribution algorithm, and supports advanced image analysis, particle detection and tracking, as well as providing improved vibration correction.

The new software is designed for use across the complete NanoSight NTA range and will be integral to all new systems shipped, while existing users can download their free upgrade via the appropriate product page on the Malvern website:

• NanoSight NS300
• NanoSight LM10
• NanoSight NS500

Malvern NanoSight systems use Nanoparticle Tracking Analysis (NTA) to characterize nanoparticles in solution in the size range 10 nm to 2000 nm (depending on the sample). Each particle is analyzed individually by direct observation and measurement of diffusion events.

This particle-by-particle methodology produces high resolution results for particle size distribution and concentration, while visual validation provides additional data confidence. Both particle size and concentration are measured, while a fluorescence mode provides differentiation of labeled or naturally fluorescing particles.

NTA 3.0 features automatic, integrated hardware detection and communication for all the systems in the NanoSight range. Compared with previous versions it generates fewer files per experiment and results are displayed on clear, concise spreadsheets. Particle size distributions are shown as histograms for easy interpretation.

NanoSight NTA systems are part of Malvern’s expanding portfolio for characterization at the nanoscale. By updating software for greater ease of use and more efficient testing, NanoSight NTA users can be sure of getting the best possible performance from their system. Visit the Malvern website for details or to download:

• NanoSight NS300
• NanoSight LM10
• NanoSight NS500

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Malvern Completes Acquisition of MicroCal
Company announces purchase of Archimedes product from Affinity Biosensors.
Friday, July 25, 2014
Malvern to Acquire MicroCal Business from GE
Malvern Instruments has entered into an agreement with GE Healthcare Life Sciences to acquire the company’s MicroCal™ microcalorimetry business.
Wednesday, June 04, 2014
Regional Growth Fund Success Sees Malvern Instruments Stepping up UK Recruitment
£3 million support from the UK Government’s Regional Growth Fund (RGF) will lead to the creation of 47 new jobs in the UK over the next five years.
Tuesday, May 20, 2014
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos